Skip to main content
Equibles

MetLife Investment Management, LLC

Position in ALEC — Alector, Inc.

CIK 1529735 Whippany, NJ
Back to ALEC Full portfolio

Position in ALEC

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$117,978
+$40,131 QoQ
Shares Held
58,696
+62.1% QoQ
Ownership
0.053%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#68
of 140 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ALEC Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MetLife Investment Management, LLC holds $433,929,439 across 249 Biotechnology names. ALEC ranks #228 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 HALO
Halozyme Therapeutics, Inc.
 402,605 $31,511,893
2 PRAX
Praxis Precision Medicines, Inc.
 90,543 $30,312,890
3 VRTX
Vertex Pharmaceuticals Inc / Ma
 58,072 $28,846,104
4 FTRE
Fortrea Holdings Inc.
 1,362,169 $23,701,740
5 AXSM
Axsome Therapeutics, Inc.
 89,662 $21,946,567
6 IMNM
Immunome Inc.
 859,076 $18,203,820
7 REGN
Regeneron Pharmaceuticals, Inc.
 22,880 $14,266,595
8 CYTK
Cytokinetics Inc
 140,046 $11,930,518

All Filings in ALEC

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $117,978 58,696
2026-03-31 $77,847 36,208
2025-09-30 $85,307 28,820
2024-12-31 $10,334 5,468
2024-09-30 $234,719 50,369
2024-06-30 $228,675 50,369
2024-03-31 $207,166 34,413
2023-12-31 $253,963 31,825
2023-09-30 $206,226 31,825
2023-06-30 $191,268 31,825
2023-03-31 $196,996 31,825
2022-12-31 $293,744 31,825
2022-09-30 $301,064 31,825
2022-06-30 $323,342 31,825
2022-03-31 $453,506 31,825
2021-12-31 $424,336 20,549
2021-09-30 $468,928 20,549
2021-06-30 $389,875 18,717
2021-03-31 $376,960 18,717
2020-12-31 $314,915 20,814
2020-09-30 $219,275 20,814
2020-06-30 $508,694 20,814
2020-03-31 $346,651 14,366